| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 1.23e-04 | 7 | 49 | 2 | GO:0030628 | |
| GeneOntologyCellularComponent | U2AF complex | 1.12e-04 | 7 | 49 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | SCAR complex | 3.50e-04 | 12 | 49 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase, V0 domain | 3.50e-04 | 12 | 49 | 2 | GO:0033179 | |
| Domain | Cytoplasmic_FMR1-int | 7.02e-06 | 2 | 50 | 2 | IPR008081 | |
| Domain | FragX_IP | 7.02e-06 | 2 | 50 | 2 | PF05994 | |
| Domain | DUF1394 | 4.20e-05 | 4 | 50 | 2 | PF07159 | |
| Domain | DUF1394 | 4.20e-05 | 4 | 50 | 2 | IPR009828 | |
| Domain | U2AF_small | 6.99e-05 | 5 | 50 | 2 | IPR009145 | |
| Domain | GDS_CDC24_CS | 1.54e-04 | 39 | 50 | 3 | IPR001331 | |
| Domain | DH_1 | 6.40e-04 | 63 | 50 | 3 | PS00741 | |
| Domain | RhoGEF | 8.00e-04 | 68 | 50 | 3 | SM00325 | |
| Domain | RhoGEF | 8.71e-04 | 70 | 50 | 3 | PF00621 | |
| Domain | DH_2 | 8.71e-04 | 70 | 50 | 3 | PS50010 | |
| Domain | DH-domain | 9.08e-04 | 71 | 50 | 3 | IPR000219 | |
| Domain | - | 9.08e-04 | 71 | 50 | 3 | 1.20.900.10 | |
| Domain | ZnF_C3H1 | 7.32e-03 | 48 | 50 | 2 | SM00356 | |
| Domain | HEAT | 7.32e-03 | 48 | 50 | 2 | PF02985 | |
| Domain | zf-CCCH | 7.62e-03 | 49 | 50 | 2 | PF00642 | |
| Domain | HEAT | 1.06e-02 | 58 | 50 | 2 | IPR000357 | |
| Domain | Znf_CCCH | 1.06e-02 | 58 | 50 | 2 | IPR000571 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.05e-05 | 175 | 41 | 6 | MM15599 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | IFNB1 CYFIP1 CAND1 PIK3CA ATP6V0A4 VPS35L VAV3 ATP6V0D2 XRCC5 ITGB2 NOS3 CYFIP2 KPNB1 | 1.09e-05 | 1128 | 41 | 13 | M1036 |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.15e-05 | 103 | 41 | 5 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.32e-05 | 106 | 41 | 5 | M27077 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.40e-05 | 184 | 41 | 6 | M41809 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CYFIP1 CAND1 PIK3CA ATP6V0A4 VPS35L VAV3 ATP6V0D2 XRCC5 ITGB2 NOS3 CYFIP2 KPNB1 | 1.66e-05 | 995 | 41 | 12 | MM14661 |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 7.92e-05 | 29 | 41 | 3 | M47717 | |
| Pathway | PID_CDC42_REG_PATHWAY | 8.78e-05 | 30 | 41 | 3 | M83 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 8.78e-05 | 30 | 41 | 3 | M47738 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 1.53e-04 | 36 | 41 | 3 | M26923 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 1.72e-04 | 7 | 41 | 2 | M47407 | |
| Pathway | WP_G13_SIGNALING | 1.79e-04 | 38 | 41 | 3 | M39606 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 1.79e-04 | 38 | 41 | 3 | MM14519 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.80e-04 | 418 | 41 | 7 | MM15587 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 2.09e-04 | 40 | 41 | 3 | M39695 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.43e-04 | 439 | 41 | 7 | MM15595 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING | 2.60e-04 | 43 | 41 | 3 | M39744 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.83e-04 | 450 | 41 | 7 | M27078 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 3.18e-04 | 46 | 41 | 3 | MM15837 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.26e-04 | 114 | 41 | 4 | MM14814 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY | 3.61e-04 | 48 | 41 | 3 | MM15897 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 3.62e-04 | 213 | 41 | 5 | M18306 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.66e-04 | 10 | 41 | 2 | M47400 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 3.83e-04 | 49 | 41 | 3 | M92 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.35e-04 | 12 | 41 | 2 | M47393 | |
| Pathway | REACTOME_IRON_UPTAKE_AND_TRANSPORT | 5.69e-04 | 56 | 41 | 3 | MM15638 | |
| Pathway | PID_SHP2_PATHWAY | 5.99e-04 | 57 | 41 | 3 | M100 | |
| Pathway | REACTOME_IRON_UPTAKE_AND_TRANSPORT | 6.31e-04 | 58 | 41 | 3 | M962 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M47398 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 6.54e-04 | 137 | 41 | 4 | M5669 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 7.68e-04 | 143 | 41 | 4 | M27107 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.72e-04 | 532 | 41 | 7 | M27870 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 8.46e-04 | 15 | 41 | 2 | M47663 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.09e-03 | 17 | 41 | 2 | M10066 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.09e-03 | 17 | 41 | 2 | MM1372 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.14e-03 | 71 | 41 | 3 | MM15604 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.28e-03 | 74 | 41 | 3 | M41814 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.28e-03 | 74 | 41 | 3 | M160 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 1.37e-03 | 19 | 41 | 2 | M273 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 1.37e-03 | 19 | 41 | 2 | M16991 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.39e-03 | 76 | 41 | 3 | MM15442 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 1.52e-03 | 20 | 41 | 2 | MM1437 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 1.52e-03 | 20 | 41 | 2 | M47737 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 1.52e-03 | 20 | 41 | 2 | MM1496 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.67e-03 | 21 | 41 | 2 | M8601 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.67e-03 | 21 | 41 | 2 | MM1463 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.72e-03 | 82 | 41 | 3 | M1021 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.74e-03 | 302 | 41 | 5 | M39719 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 1.84e-03 | 22 | 41 | 2 | M16563 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 2.01e-03 | 23 | 41 | 2 | MM1470 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.01e-03 | 23 | 41 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.01e-03 | 23 | 41 | 2 | M18719 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.04e-03 | 87 | 41 | 3 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.11e-03 | 88 | 41 | 3 | M41810 | |
| Pathway | WP_ANGIOGENESIS | 2.19e-03 | 24 | 41 | 2 | M39556 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.19e-03 | 24 | 41 | 2 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.19e-03 | 24 | 41 | 2 | MM1373 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 2.19e-03 | 24 | 41 | 2 | M4791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 2.37e-03 | 25 | 41 | 2 | M47716 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 2.42e-03 | 478 | 41 | 6 | M27620 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.43e-03 | 326 | 41 | 5 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.43e-03 | 649 | 41 | 7 | MM15690 | |
| Pathway | PID_VEGFR1_PATHWAY | 2.57e-03 | 26 | 41 | 2 | M226 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 2.70e-03 | 96 | 41 | 3 | M16121 | |
| Pathway | BIOCARTA_VEGF_PATHWAY | 2.77e-03 | 27 | 41 | 2 | M12975 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.77e-03 | 27 | 41 | 2 | M27422 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.19e-03 | 29 | 41 | 2 | M27171 | |
| Pathway | PID_IGF1_PATHWAY | 3.19e-03 | 29 | 41 | 2 | M125 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 3.37e-03 | 511 | 41 | 6 | MM15330 | |
| Pathway | WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY | 3.41e-03 | 30 | 41 | 2 | M39592 | |
| Pathway | PID_NECTIN_PATHWAY | 3.41e-03 | 30 | 41 | 2 | M72 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.41e-03 | 30 | 41 | 2 | MM15170 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 3.41e-03 | 30 | 41 | 2 | M506 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 3.64e-03 | 31 | 41 | 2 | M47396 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.64e-03 | 31 | 41 | 2 | MM14886 | |
| Pathway | PID_AVB3_OPN_PATHWAY | 3.64e-03 | 31 | 41 | 2 | M63 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 3.64e-03 | 31 | 41 | 2 | MM15467 | |
| Pathway | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | 3.64e-03 | 31 | 41 | 2 | MM15639 | |
| Pathway | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | 3.64e-03 | 31 | 41 | 2 | M991 | |
| Pubmed | CAND1 WDR11 GLG1 DDX56 XRCC5 ITGB2 M6PR GPAT4 IL6ST CYFIP2 KPNB1 | 6.57e-07 | 1168 | 50 | 11 | 19946888 | |
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 2.03e-06 | 2 | 50 | 2 | 38128786 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33691379 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 2.03e-06 | 2 | 50 | 2 | 24357318 | |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 2.03e-06 | 2 | 50 | 2 | 35198906 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 34327661 | ||
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 2.03e-06 | 2 | 50 | 2 | 29752658 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35567753 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31324746 | ||
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 4.22e-06 | 22 | 50 | 3 | 21946561 | |
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | 6.07e-06 | 3 | 50 | 2 | 8586425 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19147786 | ||
| Pubmed | Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. | 6.07e-06 | 3 | 50 | 2 | 36030305 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19505983 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 15800125 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16839745 | ||
| Pubmed | Glomerular endothelial PI3 kinase-α couples to VEGFR2, but is not required for eNOS activation. | 6.07e-06 | 3 | 50 | 2 | 21937609 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 25257463 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 9001233 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15294869 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24887566 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 27605705 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 20228810 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 7558001 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.84e-05 | 807 | 50 | 8 | 22681889 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.84e-05 | 807 | 50 | 8 | 30575818 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 24936148 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 27713121 | ||
| Pubmed | a4, a unique kidney-specific isoform of mouse vacuolar H+-ATPase subunit a. | 2.02e-05 | 5 | 50 | 2 | 11498539 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 11438699 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 36658650 | ||
| Pubmed | Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. | 3.03e-05 | 6 | 50 | 2 | 31853374 | |
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 3.03e-05 | 6 | 50 | 2 | 12783884 | |
| Pubmed | Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. | 3.03e-05 | 6 | 50 | 2 | 33846634 | |
| Pubmed | The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation. | 4.23e-05 | 7 | 50 | 2 | 31915252 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 30687000 | ||
| Pubmed | CtIP-mediated resection is essential for viability and can operate independently of BRCA1. | 4.23e-05 | 7 | 50 | 2 | 24842372 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 9237760 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TIGAR CAND1 LDB1 WDR11 RPS6KB1 VPS35L DDX56 MCF2L XRCC5 FARP2 | 4.31e-05 | 1489 | 50 | 10 | 28611215 |
| Pubmed | CYFIP1 CAND1 KMT2B WDR11 GLG1 DDX56 MORC2 DHX29 CYFIP2 FARP2 | 4.51e-05 | 1497 | 50 | 10 | 31527615 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 24227842 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 32371981 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 27368196 | ||
| Pubmed | Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. | 5.64e-05 | 8 | 50 | 2 | 15249579 | |
| Pubmed | Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion. | 5.64e-05 | 8 | 50 | 2 | 25892652 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 11279232 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 21035469 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 38981622 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 27522498 | ||
| Pubmed | The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. | 9.05e-05 | 10 | 50 | 2 | 15249583 | |
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 9.05e-05 | 10 | 50 | 2 | 15048123 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 18708672 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.01e-04 | 759 | 50 | 7 | 35915203 | |
| Pubmed | 1.04e-04 | 63 | 50 | 3 | 37052853 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 9927325 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 36793866 | ||
| Pubmed | 1.55e-04 | 565 | 50 | 6 | 20458337 | ||
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 22222486 | ||
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 34508581 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.74e-04 | 1425 | 50 | 9 | 30948266 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 27119228 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.99e-04 | 847 | 50 | 7 | 35235311 | |
| Pubmed | Molecular architecture underlying fluid absorption by the developing inner ear. | 2.10e-04 | 15 | 50 | 2 | 28994389 | |
| Pubmed | 2.62e-04 | 215 | 50 | 4 | 30462309 | ||
| Pubmed | EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy. | 2.72e-04 | 17 | 50 | 2 | 26905199 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 21257963 | ||
| Pubmed | Comparative mapping of the imprinted U2afbpL gene on mouse chromosome 11 and human chromosome 5. | 2.72e-04 | 17 | 50 | 2 | 7956352 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.95e-04 | 1203 | 50 | 8 | 29180619 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 9463375 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 12799088 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 3.16e-04 | 226 | 50 | 4 | 37839992 | |
| Pubmed | 3.20e-04 | 916 | 50 | 7 | 32203420 | ||
| Pubmed | Androglobin, a chimeric mammalian globin, is required for male fertility. | 3.41e-04 | 19 | 50 | 2 | 35700329 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 3.66e-04 | 1242 | 50 | 8 | 30973865 | |
| Pubmed | BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma. | 3.79e-04 | 20 | 50 | 2 | 32509391 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.96e-04 | 1257 | 50 | 8 | 36526897 | |
| Pubmed | 4.32e-04 | 963 | 50 | 7 | 28671696 | ||
| Pubmed | 4.47e-04 | 103 | 50 | 3 | 21706016 | ||
| Pubmed | 4.56e-04 | 249 | 50 | 4 | 30097533 | ||
| Pubmed | The vacuolar (H+)-ATPases--nature's most versatile proton pumps. | 4.59e-04 | 22 | 50 | 2 | 11836511 | |
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 12788495 | ||
| Pubmed | Revised nomenclature for mammalian vacuolar-type H+ -ATPase subunit genes. | 4.59e-04 | 22 | 50 | 2 | 14580332 | |
| Pubmed | Neurotransmitter release: the dark side of the vacuolar-H+ATPase. | 4.59e-04 | 22 | 50 | 2 | 14597263 | |
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 17662945 | ||
| Pubmed | 5.48e-04 | 24 | 50 | 2 | 21037509 | ||
| Pubmed | 5.60e-04 | 1006 | 50 | 7 | 15226823 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 5.94e-04 | 1016 | 50 | 7 | 19056867 | |
| Pubmed | Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor. | 5.95e-04 | 25 | 50 | 2 | 2874839 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 6.89e-04 | 1367 | 50 | 8 | 32687490 | |
| Pubmed | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality. | 6.95e-04 | 27 | 50 | 2 | 28542142 | |
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 7.48e-04 | 28 | 50 | 2 | 35227662 | |
| Pubmed | Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. | 8.02e-04 | 29 | 50 | 2 | 26633882 | |
| Pubmed | 8.02e-04 | 29 | 50 | 2 | 32527007 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 8.06e-04 | 1070 | 50 | 7 | 23533145 | |
| Pubmed | 8.60e-04 | 129 | 50 | 3 | 23022380 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 8.62e-04 | 1415 | 50 | 8 | 28515276 | |
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 9.17e-04 | 31 | 50 | 2 | 20691427 | |
| Pubmed | 9.66e-04 | 1440 | 50 | 8 | 30833792 | ||
| Pubmed | 9.96e-04 | 533 | 50 | 5 | 25544563 | ||
| Pubmed | 1.03e-03 | 809 | 50 | 6 | 32129710 | ||
| Interaction | RAC1 interactions | CYFIP1 MYO1E WDR11 PIK3CA RPS6KB1 DDX56 VAV3 MCF2L SEPTIN10 IL6ST CYFIP2 KPNB1 | 6.55e-06 | 1063 | 49 | 12 | int:RAC1 |
| Cytoband | 7p13 | 8.39e-04 | 39 | 50 | 2 | 7p13 | |
| Cytoband | 5q11.2 | 1.49e-03 | 52 | 50 | 2 | 5q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p13 | 1.55e-03 | 53 | 50 | 2 | chr7p13 | |
| Cytoband | 11p15.1 | 1.98e-03 | 60 | 50 | 2 | 11p15.1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.94e-04 | 66 | 31 | 3 | 722 | |
| GeneFamily | V-type ATPases | 7.04e-04 | 23 | 31 | 2 | 415 | |
| GeneFamily | Zinc fingers CCCH-type | 1.63e-03 | 35 | 31 | 2 | 73 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.18e-03 | 206 | 31 | 3 | 682 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | b62a756b5472972156d05051a58671a58bef1f16 | |
| Drug | Orotic Acid | 2.81e-06 | 13 | 50 | 3 | ctd:D009963 | |
| Drug | fascaplysine | 3.57e-06 | 14 | 50 | 3 | ctd:C069346 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 7.13e-06 | 3 | 46 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 8.50e-05 | 9 | 46 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Chronic Lymphocytic Leukemia | 8.79e-05 | 55 | 46 | 3 | C0023434 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.16e-05 | 293 | 46 | 5 | C1708349 | |
| Disease | Stomach Neoplasms | 9.77e-05 | 297 | 46 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.02e-04 | 300 | 46 | 5 | C0024623 | |
| Disease | Drug habituation | 7.75e-04 | 115 | 46 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 7.75e-04 | 115 | 46 | 3 | C0236969 | |
| Disease | Drug abuse | 7.75e-04 | 115 | 46 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 7.75e-04 | 115 | 46 | 3 | C0013222 | |
| Disease | Drug Dependence | 7.75e-04 | 115 | 46 | 3 | C1510472 | |
| Disease | Substance Dependence | 7.75e-04 | 115 | 46 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 7.75e-04 | 115 | 46 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 7.75e-04 | 115 | 46 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 7.75e-04 | 115 | 46 | 3 | C4316881 | |
| Disease | Substance abuse problem | 7.94e-04 | 116 | 46 | 3 | C0740858 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 8.14e-04 | 27 | 46 | 2 | C1112155 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 8.76e-04 | 28 | 46 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 9.40e-04 | 29 | 46 | 2 | C1333990 | |
| Disease | Chloracne | 1.22e-03 | 33 | 46 | 2 | C0263454 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYEVFGRVQGVCFRM | 11 | P14621 | |
| VCFRMYTEDEARKIG | 21 | P14621 | |
| RFGEEILYRIDLCSM | 251 | Q9P0M2 | |
| RDGFCFRMYTRERFE | 986 | Q7Z478 | |
| VMLTCAFRYGRDDLE | 51 | P36575 | |
| MYFQRNAIERFCGEV | 126 | Q7L576 | |
| VCVEGRLYLEFMFDD | 176 | Q86U70 | |
| EFVADFRLMLETCYR | 156 | Q5HYC2 | |
| YQFRMEEIEGFRYRC | 416 | Q9NY93 | |
| DDGLDIRKAAFECMY | 1076 | Q86VP6 | |
| LRMDDYCRRKDDSYF | 131 | Q9HCD5 | |
| REGIFMEDTACFYLA | 186 | P23443 | |
| RAEVYLRKCTFDMFN | 2511 | Q9UMN6 | |
| MYFQRKAIERFCSEV | 126 | Q96F07 | |
| CTKTREFERFQEMCY | 971 | P42336 | |
| YAERREDLRGGFMLC | 51 | Q9Y6X9 | |
| FDARDCRSAQEMFTY | 196 | P29474 | |
| GMDRYLIYVDESREC | 681 | P05107 | |
| IIFSDYRLICGFMDD | 226 | Q92896 | |
| GARVKIMDDEEFAYC | 141 | Q8IUX4 | |
| VCMEYGFTDFRGLLR | 206 | Q8N9C0 | |
| PFTEYVFRIRCMKED | 291 | P40189 | |
| KRYCFGEGLARMELF | 436 | Q16696 | |
| ELSDIFYFCRKGMET | 111 | Q86UL3 | |
| RMDYLRECIFGEVKS | 831 | Q53R41 | |
| NGRLEYCLKDRMNFD | 46 | P01574 | |
| YVMSFAFCFDREEDI | 146 | Q5VU57 | |
| RYRDAAVMAFGCILE | 381 | Q14974 | |
| GRCFLERMEDFQIYE | 711 | O15068 | |
| RLNLVECDYFGMEFQ | 76 | O94887 | |
| DQVKMRGIDFFEFLC | 126 | Q9NQ88 | |
| MYCEEPFVREGLEFA | 266 | Q9Y606 | |
| RCGYFDEEMNRILAD | 1706 | P58107 | |
| KMRVFERSVYFGDSC | 231 | Q9BSU1 | |
| FFLRREGMRQYGECL | 61 | Q6UXX9 | |
| LGDVFTEEKFRYMCI | 206 | Q9UQ84 | |
| EEIKTLERYMCSRFF | 261 | Q5VWP2 | |
| FLREMGQFYEAESCL | 616 | Q8TCY9 | |
| ERRYECSECGKLFMD | 351 | O43361 | |
| FGKLVYERIFSMCVD | 241 | Q7Z3J2 | |
| RGKVQDCFYLFEMDS | 161 | P20645 | |
| LYRRCKLEEMGFTDV | 321 | Q9P0V9 | |
| RICRGNVYLKFSEMD | 191 | Q9HBG4 | |
| MEFDCEGLRRLLGKY | 1 | Q8IX04 | |
| DFRVMEKDRANCPFY | 166 | Q15695 | |
| FTTFGMEQCRRDDYD | 211 | Q15695 | |
| SMRYFDRAALFVEAC | 1146 | Q9BZH6 | |
| DFRVMEKDRANCPFY | 161 | Q15696 | |
| FTTFGMEQCRRDDYD | 206 | Q15696 | |
| NKEYPERFIECFMAE | 326 | P51854 | |
| YFMKSIDCIRAFREE | 631 | P13010 | |
| DTEMRKRLCGEFEYF | 71 | Q8N8Y2 | |
| GIAIARYDFCARDMR | 791 | Q9UKW4 | |
| VSYDMDGFCERNRDV | 511 | Q12965 | |
| DGFCERNRDVLFMDL | 516 | Q12965 |